DR. DAVID JON TAMURA M.D. NPI 1295953123

NPI Information

  • NPI: 1295953123
  • Provider Name: DR. DAVID JON TAMURA, M.D.
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 500 ALA MOANA SUITE 6-230
    HONOLULU, HI
    ZIP 96813
  • Phone: (808) 524-6115

Map and Directions

Get Directions

NPI Details

DR. David Jon Tamura, M.D. is a hematology and oncology internal medicine in Honolulu, HI with 22 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. DR. David Jon Tamura, M.D. NPI is 1295953123. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

500 ALA MOANA SUITE 6-230
HONOLULU, HI
ZIP 96813
Phone: (808) 524-6115
Fax: (808) 528-1711

The NPI 1295953123 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, fosaprepitant, 1 mg (HCPCS:J1453)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Injection, epoetin alfa, (for non-esrd use), 1000 units (HCPCS:J0885)
  • Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Injection, heparin sodium, (heparin lock flush), per 10 units (HCPCS:J1642)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
  • Liver function blood test panel (HCPCS:80076)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Unclassified drugs (HCPCS:J3490)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
  • Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Psa (prostate specific antigen) measurement, total (HCPCS:84153)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
  • Thyroxine (thyroid chemical), free (HCPCS:84439)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Magnesium level (HCPCS:83735)
  • Uric acid level, blood (HCPCS:84550)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Drawing of blood for a medical problem (HCPCS:99195)
  • Phosphate level (HCPCS:84100)

The enumeration date for this NPI number is 4/24/2007 and was last updated on 5/14/2024.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RX0202XInternal MedicineMedical OncologyMD15078HAWAIINo
2207RH0003XInternal MedicineHematology & OncologyMD15078HAWAIIYes

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.